Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Here's a chart that the Federal Reserve hoped it wouldn't see: Inflation has turned upwards after making some progress in the ...
All three major stock indexes were off their lowest levels of Wednesday's session after President Trump suggested that Russian President Vladimir Putin was receptive to talks about its war with ...
There are three companies reporting earnings after the market closes on Wednesday whose stock have had a stunning rally of late. Shares of AppLovin are up 700% over the last 12 months, and Robinhood ...
January 13, 2025--STAAR Surgical Company (NASDAQ: STAA), the global leader in ... as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement ...
Cybersecurity software maker Rapid7 (NASDAQ:RPD) will be announcing earnings results tomorrow after market close. Here’s what you need to know. Loop Capital analyst Yun Kim lowered the firm’s ...
The results exceeded Wall Street expectations. LOS ANGELES, January 22, 2025--Cathay General Bancorp (the "Company," "we," "us," or "our") (Nasdaq: CATY), the holding company for Cathay Bank ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE ...
SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor ...
In this article, we are going to take a look at where Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stands against the other diabetes stocks. Global Growth and Innovation in Diabetes Care ...
Published first on TheFly – the ultimate source for real-time, market-moving PriceSmart ( NASDAQ:PSMT ) Full Year 2024 Results Key Financial Results Revenue: US$4.91b (up 11% from FY 2023).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results